NFG
HZNP

Nations Financial Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Nations Financial Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,849
Closed -$792K – 653
2023
Q3 		$792K Hold
6,849
– – 0.08% 265
2023
Q2 		$704K Sell
6,849
-4,030
-37% -$425K 0.07% 294
2023
Q1 		$1.19M Buy
10,879
+1,850
+20% +$204K 0.12% 196
2022
Q4 		$1.03M Sell
9,029
-3,000
-25% -$249K 0.12% 218
2022
Q3 		$744K Sell
12,029
-1,214
-9% -$84.8K 0.11% 210
2022
Q2 		$1.06M Buy
13,243
+4,303
+48% +$407K 0.14% 184
2022
Q1 		$941K Buy
8,940
+2,703
+43% +$263K 0.11% 199
2021
Q4 		$672K Buy
6,237
+985
+19% +$107K 0.09% 235
2021
Q3 		$575K Buy
+5,252
New +$545K 0.09% 246

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Nations Financial Group's HZNP Position: Q4 2023 in Review

Nations Financial Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 6,849 shares — an estimated $792K sold.

Nations Financial Group first reported a position in HZNP in Q3 2021 and held it in 9 quarters. The position peaked at $1.19M in Q1 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Nations Financial Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Nations Financial Group sold 6,849 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $792K.
  • Nations Financial Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2021 and held it in 9 quarters.
  • Nations Financial Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.19M in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Nations Financial Group's 13F filing for Q4 2023, filed 9 Feb 2024.